Skip to main content

Table 1 Baseline characteristics of study population

From: Performance of the SarQoL quality of life tool in a UK population of older people with probable sarcopenia and implications for use in clinical trials: findings from the SarcNet registry

  All included participants
(n = 147)
Participants by 6 month follow up status
Telephone
(n = 117)
Face-to-face
(n = 8)
Dropped out
(n = 22)
Mean age (years) (SD) 77.6 (7.3) 77.0 (7.2) 78.9 (6.0) 79.8 (7.8)
Female sex (%) 72 (49) 56 (48) 3 (38) 13 (59)
Mean SPPB (SD) 5.5 (2.3) 5.8 (2.4) 6.4 (1.8) 5.6 (2.5)
Max handgrip strength (kg) (SD)
 Men 27.2 (9.4)
(n = 70)
26.8 (9.2) (n = 61) 32.8 (12.6) (n = 5) 26.6 (9.2)
(n = 9)
 Women 15.7 (6.1)
(n = 69)
15.5 (6.4) (n = 56) 16.7 (3.1) (n = 3) 16.5 (5.2)
(n = 13)
Mean walk speed
(m/s) (SD)
0.61 (0.24) (n = 142) 0.61 (0.24) (n = 113) 0.64 (0.21) (n = 8) 0.62 (0.23)
(n = 21)
Median chair stand time
(s) [IQR]
24.0 [32.0–17.4] (n = 106) 23.0 [14.5] (n = 84) 21.8 [26.0] (n = 6) 28.0 [7.6]
(n = 16)
Mean SARC-F score (SD) 5.28 (1.82) 5.28 (1.85) 4.38 (1.19) 5.59 (1.82)
Mean skeletal muscle mass index (kg/m2) (SD)
 Men 7.84 (1.21)
(n = 70)
7.82 (1.11) (n = 57) 7.75 (0.92) (n = 5) 8.03 (2.01)
(n = 8)
 Women 6.65 (1.13)
(n = 69)
6.76 (1.23) (n = 54) 6.12 (0.30) (n = 3) 6.30 (0.61)
(n = 12)
SarQoL score (SD)
(best = 100)
50.9 (11.9) 51.1 (12.6) 52.6 (7.6) 49.5 (9.3)
Physical and mental health 55.5 (15.6) 55.4 (15.9) 57.9 (7.8) 55.3 (16.3)
Locomotion 48.8 (18.1) 49.1 (18.7) 43.8 (12.8) 48.8 (17.2)
Body composition 58.4 (17.2) 58.0 (17.7) 59.9 (12.4) 59.8 (16.8)
Functionality 52.6 (12.8) 52.7 (13.5) 55.1 (7.7) 51.4 (10.6)
Activities of daily living 46.1 (14.9) 46.2 (15.4) 52.3 (10.9) 43.3 (13.1)
Leisure activities 36.1 (17.3) 36.5 (18.2) 31.2 (5.9) 36.3 (15.1)
Fears 67.5 (19.1) 68.9 (19.8) 68.8 (22.2) 59.7 (11.5)*
  1. *p < 0.05 compared to telephone follow-up group
  2. Subdomain scores all normalised to 0–100 scale (best = 100)